Quality of life indicators in patients with diffuse brain gliomas
Authors:
- St. Petersburg Military Medical Academy Named After S. M. KirovSKSt. Petersburg Military Medical Academy Named After S. M. Kirov
- M. Yu. ProkudinMPM. Yu. Prokudin
- B. V. MartynovBMB. V. Martynov
- V. V. ArsenievaVAV. V. Arsenieva
- I. V. LitvinenkoILI. V. Litvinenko
- D. V. SvistovDSD. V. Svistov
- E. Yu. KlimenkovaEKE. Yu. Klimenkova
- O. A. KlitsenkoOKO. A. Klitsenko
- FSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of the Russian FederationFFFSBEI HE North-Western State Medical University named after I. I. Mechnikov of the Ministry of Health of the Russian Federation
- R. S. MartynovRMR. S. Martynov
- K. A. ChemodakovaKCK. A. Chemodakova
- N. K. VasilievaNVN. K. Vasilieva
- 22 February 2024
- journal article
- research article
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 2,p. 213-224
Abstract
The incidence of primary brain tumors is increasing worldwide. When assessing the treatment delivered to patients with brain gliomas, their quality of life (QOL) is an essential criterion for consideration. It is necessary to search for and specify the factors, which determine the QOL changes in patients with brain tumors. The QOL indicators for patients with brain gliomas were assessed in terms of the following factors: clinical (presence of epileptic seizures, seizures type and frequency, antiepileptic drug treatment, presence of speech disorders and pareses), demographic (sex), age of diagnosis, social (level of education, employment, marital status), molecular-genetic (presence of IDH1/2 mutation, 1p/19q codeletion), and morphological (malignancy degree, tumor histological characteristics). The QOL of 48 patients with diffuse brain gliomas was tested according to the objectives of the study. The QOLIE-31 questionnaire (version 1.0) indicates that diffuse glioma patients with epilepsy have statistically significant decrease in such QOL spheres as seizures worry (p<0.0001), cognitive functioning (p=0.0043), antiepileptic drug effect (p=0.0002), social functioning (p=0.0029), as well as in the total score (p=0.0053). In addition, such factors as age, gender, tumor malignancy degree, and its histological type have a statistically significant effect on the QOL of patients with diffuse brain gliomas before surgery. Thus, the treatment of patients with diffuse brain gliomas requires a thorough study and a multidisciplinary approach, including such specialists as a neurologist, oncologist, chemotherapist, radiologist, neuropsychologist, and psychiatrist, in addition to a neurosurgeon.Keywords
This publication has 21 references indexed in Scilit:
- Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma—results of a multicenter studySupportive Care in Cancer, 2020
- Perioperative and Postoperative Quality of Life in Patients with Glioma–A Longitudinal Cohort StudyWorld Neurosurgery, 2018
- Optimal Therapies for Newly Diagnosed Elderly Patients with GlioblastomaCurrent Treatment Options in Oncology, 2017
- Epilepsy and brain tumors2016
- Occurrence and predictors of the fatigue in high-grade glioma patientsNeurological Sciences, 2015
- Psychometric evaluation of the Serbian version of the Quality of Life in Epilepsy Inventory-31 (QOLIE-31)Seizure: European Journal of Epilepsy, 2010
- An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patientsEuropean Journal of Cancer, 2010
- Fatigue in low-grade gliomaJournal of Neuro-Oncology, 2008
- Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scoresJournal of Neuro-Oncology, 1992
- Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance statusJournal of Neuro-Oncology, 1992